AAA announces completion of €40 million capital increase, Dompé acquires 7.7% stake, Eugenio Aringhieri joins AAA Board

Pierrel Research International AG has been awarded a conduction of a phase III study in the area of tumoral pathologies

Advanced Accelerator Applications receives GMP approval to manufacture Lutate for treatment of NeuroEndocrine Tumors

Advanced Accelerator Applications Announces Research and Supply Partnership with the Institut Curie in Paris

Advanced Accelerator Applications (St. Genis, France) acquires BioSynthema Inc (St. Louis, Missouri) to enter radiopharmaceutical cancer therapeutic market

Leading European Manufacturers found EMMA

Investment of Advanced Accelerator Applications in Atreus Pharmaceuticals Corporation to develop Annexin Imaging Business

The work in progress of the THERANEAN project start with the launch meeting at ARRONAX Center

AAA inaugurates in Meldola its third Italian site dedicated to the research and development and production of FDG

Advanced Accelerator Applications (“AAA”) Growth Continues with the acquisition of Gipharma